Online seminar  /  June 14, 2022, 2-3.00 p.m. CET

Automated GMP-compliant production of cell and gene therapies

Automated production, analytics and quality control are becoming increasingly important in the production of cell and gene therapies. Breakthroughs in T-cell therapy, mRNA production and vaccine production and the like are leading to ever new therapies and interventions. With more than 2600 ongoing clinical trials of ATMPs in 2021 and more than 300 of these trials in phase III, rapidly increasing production capacity will be needed in the coming years. To meet this capacity, new and further developments in production technology are needed in order to efficiently, robustly and reliably manufacture the personalized medicine of the future.

About the seminar

This online seminar will cover the challenges of fully automated manufacturing of autologous and allogeneic cell and gene therapies. The difficulties as well as new concepts to support the therapies will be highlighted.

Finally, all participants will have the opportunity to ask individual questions. In addition, upon completion of the online seminar, you will receive the presentation slides used or an equivalent content document as a script. The online seminar is conducted on Microsoft Teams.

Key Facts

  • Date: Monday, June 14, 2022, 2-3.00 p.m.
  • Participation fee: free of charge
  • Number of participants: at least 5
  • Implementation: Microsoft Teams